Company / Depreciation & Amortization
TriSalus Life Sciences, Inc. Depreciation & Amortization History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$744.0K
FY2025
5-year range
$398.0K / $744.0K
FY2023-FY2025
Trend
+8.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $398,000 to $744,000 over the past 2 years.
Based on SEC 10-K filings.
$744,000 in FY2025.
Increased from $398,000 to $744,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 8.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.11 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $744.0K | +8.8% |
| FY2024 | $684.0K | +71.9% |
| FY2023 | $398.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026